Gossamer Bio Is A Good Speculative Buy On Seralutinib For PAH And PH-ILD
Gossamer Bio's Seralutinib shows promise for PAH and PH-ILD treatment. The main event comes with its topline results in Q4 ...
Organon & Co. (OGN) Q4 2024 Earnings Call Transcript
Q4 2024 Earnings Conference Call February 13, 2025 8:30 AM ETCompany ParticipantsJennifer Halchak - VP, IRKevin Ali - ...
Business Wire21h
Organon Reports Results for the Fourth Quarter and Full Year Ended December 31, 2024
Organon (NYSE: OGN) today announced its results for the fourth quarter and full year ended December 31, 2024. “In 2024 we achieved our third year of constant currency revenue growth and delivered ...
Hosted on MSN3d
Wall Street Predict 92% Upside for This Dividend Stock: Should You Buy It Now?
Merck (MRK) is a leading global healthcare company recognized for its groundbreaking pharmaceutical products and vaccines.
Hosted on MSN6d
Wall Street Analysts Thought Merck Stock Had 10% Downside Risk Heading Into Earnings. That Materialized, So What’s Next?
Merck & Co. (NYSE:MRK) is a prominent American multinational pharmaceutical company many investors know for its brand-name ...